Using hydrogen sulfide to design and develop drugs.
Expert Opin Drug Discov. 2015 Nov 23;
Authors: Calderone V, Martelli A, Testai L, Citi V, Breschi MC
Abstract
INTRODUCTION: Hydrogen sulfide (H2S) is an endogenous gasotransmitter, involved in the regulation of several biological functions. Conversely, impaired biosynthesis of H2S is associated with important diseases. This paves the way to exciting pharmacological perspectives for drugs acting on the "H2S system". Areas covered: At the beginning of this manuscript, the authors present the biological roles and mechanisms of action of hydrogen sulfide. The authors then discuss the developments in the modulation of the H2S system via heterogeneous molecules, which behave as sources of exogenous H2S, and are promising drugs for a number of diseases. Expert opinion: The rate of H2S generation, the physicochemical characteristics and the bioavailability greatly affect the overall pharmacological profile of each H2S-releasing compound. Therefore, the development of broad collections of original moieties endowed with heterogeneous rates/mechanisms of H2S-release and a variety of physicochemical, biological and pharmacological features is the most timely and compelling issue in the field of H2S-based drug discovery.
PMID: 26593865 [PubMed - as supplied by publisher]
from #PubMed 3 via ola Kala on Inoreader http://ift.tt/1LzJKcU
via IFTTT
from #Med Blogs by Alexandros G.Sfakianakis via paythelady61 on Inoreader http://ift.tt/1jjRCca
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου